COMMON STOCK PURCHASE WARRANT AINOS, INC.Common Stock Purchase Warrant • August 12th, 2022 • Ainos, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Cede & Co. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 11, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ainos, Inc., a company incorporated under the laws of the State of Texas (the “Company”), up to 897,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warran
AINOS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY, as Warrant Agent Warrant Agency Agreement Dated as of August 11, 2022 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • August 12th, 2022 • Ainos, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of August 11, 2022 (“Agreement”), between Ainos, Inc., a corporation organized under the laws of the State of Texas (the “Company”), and American Stock Transfer & Trust Company (the “Warrant Agent”).
AINOS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • August 12th, 2022 • Ainos, Inc. • Pharmaceutical preparations • New York
The undersigned, Ainos, Inc., a Texas corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”) an aggregate of 780,000 units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional 117,000 Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional 117,000 Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purchase one share of Common St
